It has been known since the 1970s that chronic myeloid leukemia (CML) is almost universally associated with a translocation of chromosomes 9 and 22, which leads to a fusion oncoprotein, BCR-ABL1 [187]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.